Skip to main content
Log in

Clinical polymorphism of cystinosis encephalopathy. Results of treatment with cysteamine

  • Published:
Journal of Inherited Metabolic Disease

Summary

Of the 26 cystinotic patients over 19 years of age followed in our institution, 7 developed CNS complications at a mean age of 23 years. Two forms were observed. The first, associating cerebellar and pyramidal signs, mental deterioration and finally pseudo-bulbar palsy, may be called cystinosis encephalopathy. The other form resembled a stroke-like episode with coma and hemiplegia or milder symptoms. Hydrocephalus was rare and not associated with clinical symptoms in this series. Cysteamine was administered for longer than 6 months to 4 of the patients with encephalopathy. Two had an almost complete disappearance of their symptoms including the gross abnormalities of MR imaging in one; one improved partially and remained stable, and one continued to deteriorate but was suspected of noncompliance. These results suggest that cysteamine may be an effective treatment of cystinosis encephalopathy and encourage prescription of this drug in cystinosis in order to prevent this complication

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bakchine H, Niaudet P, Gagnadoux MF, Broyer M, Czernichow P (1984) Diabète induit par les corticoîdes chez 6 enfants après transplantation rénale.Arch Fr Pediatr 47: 261–264.

    Google Scholar 

  • Broyer M, Guillot M, Gubler MC, Habib R (1981) Infantile cystinosis: a reappraisal of early and late symptoms.Adv Nephrol 10: 137–166.

    Google Scholar 

  • Broyer M, Tête MJ, Gubler MC (1987) Late symptoms in infantile cystinosis.Pediatr Nephrol 1: 519–524.

    Google Scholar 

  • Chan A, Lynch M, Bailey JD, Ezrin C, Fraser D (1970) Hypothyroidism in cystinosis.Am J Med 48: 678–692.

    Google Scholar 

  • Dufier JL, Dhermy P, Gubler MC, Gagnadoux MF, Broyer M (1987) Ocular change in long term evolution of infantile cystinosis.Ophthal Paediatr Genet 8: 131–137.

    Google Scholar 

  • Ehrich JHH, Stoeppler L, Offner G, Brodehl J (1979) Evidence for cerebral involvement in nephropathic cystinosis.Neuropediatrics 20: 128–137.

    Google Scholar 

  • Fink JK, Brouwers P, Barton N (1989) Neurologic complications in long-standing nephropathic cystinosis.Arch Neurol 4: 543–548.

    Google Scholar 

  • Gahl W, Schneider J, Thoene J, Chesney R (1986) Course of nephropathic cystinosis after age 10 years.J Pediatr 109: 605–608.

    Google Scholar 

  • Gahl WA, Reed GF, Thoene JG, et al. (1987) Cysteamine therapy for children with nephropathic cystinosis.N Engl J Med 316: 971–977.

    Google Scholar 

  • Gahl WA, Dalakas M, Charnas L, Chen K (1988) Myopathy and cystine storage in muscles in a patient with nephropathic cystinosis.N Engl J Med 48: 1461–1464.

    Google Scholar 

  • Gahl, WA, Charnas L, Markello T, Bernardini I, Ishak K, Dalakas M (1992) Parenchymal organ cystine depletion with long term cysteamine therapy.Biochem Med Metab Biol 48: 275–285.

    Google Scholar 

  • Jonas AJ, Conley SB, Marshall R, Johnson RA, Marks M, Rosenberg H (1987) Nephropathic cystinosis with central nervous system involvement.Am J Med 83: 966–970.

    Google Scholar 

  • Kaiser-Kupfer ML, Carysi RC, Monkler DS, Gahl WA (1986) Long-term ocular manifestations in nephropathic cystinosis.Arch Ophthalmol 104: 706–711.

    Google Scholar 

  • Levine S, Paparo G (1982) Brain lesions in a case of cystinosis.Acta Neuropathol 57: 217–220.

    Google Scholar 

  • Lucky AW, Howley PM, Megyesi J, Spielberg SP, Schulman JD (1977) Endocrine studies in cystinosis: compensated primary hypothyroidism.J Pediatr 91: 204–210.

    Google Scholar 

  • Markello TC, Bernardini IM, Ghal WA (1993) Improved renal function in children with cystinosis treated with cysteamine.N Engl J Med 328: 1157–1162.

    Google Scholar 

  • Nichols S, Press G, Schneider J, Trauner D (1990) Cortical atrophy and cognitive performance in infantile nephropathic cystinosis.Pediatr Neurol 6: 379–381.

    Google Scholar 

  • Ross DL, Strife CF, Towbin R, Bove KE (1982) Non absorptive hydrocephalus associated with nephropathic cystinosis.Neurology 32: 1330–1334.

    Google Scholar 

  • Smith M, Furlong CE, Greebe AA, Schneider JA (1987) Cystine binding protein assay.Methods Enzymol 143: 144–148.

    Google Scholar 

  • Sonies B, Ekman E, Anderzson H, Adamson M (1990) Swallowing dysfunction in nephropathic cystinosis.N Engl J Med 323: 565–570.

    Google Scholar 

  • Strayer DS (1979) Cystinosis and a dissecting aortic aneurism in a 7-year-old boy.Am J Dis Child 133: 436–438.

    Google Scholar 

  • Theodoropoulos D, Krasnevich D, Kaiser-Kupfer M, Gahl W (1993) Classic nephropathic cystinosis as an adult disease.J Am Med Assoc 270: 2200–2204.

    Google Scholar 

  • Trauner D, Chase C, Scheller J, Katz B, Schneider J (1988) Neurologic and cognitive deficits in children with cystinosis.J Pediatr 112: 912–914.

    Google Scholar 

  • Van Lierde A, Colombo D, Marchesi F, Giani M, Consalvo G, Edefonti A, Ghio L (1994) Hemiparesia in a girl with cystinosis and renal transplant.Eur J Pediatr 153: 702–703.

    Google Scholar 

  • Vogel DG, Malekzadeh MH, Cornfold ME, Schneider JA, Shields VM, Vinters HV (1990) Central nervous system involvement in nephropathic cystinosis.J Neuropathol Exp Neurol 49: 591–599.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Broyer, M., Tête, M.J., Guest, G. et al. Clinical polymorphism of cystinosis encephalopathy. Results of treatment with cysteamine. J Inherit Metab Dis 19, 65–75 (1996). https://doi.org/10.1007/BF01799350

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01799350

Keywords

Navigation